Männedorf, Switzerland 1/15/19—Laboratory instrument and solutions provider Tecan has named Dr. Achim von Leoprechting as its new CEO, effective April 1, replacing Dr. David Martyr who is retiring. Dr. von Leoprechting currently serves as head of the Partnering Business Division and will continue in that role as well as his new role until a replacement is found. “It is the first time in the history of Tecan that the Board was able to pick an internal successor—a clear evidence of the strong leadership team that was formed in recent years. The internal appointment also maximizes continuity of the corporate strategy,” stated Tecan Chairman Dr. Lukas Braunschweiler. “Under Achim von Leoprechting’s leadership, Tecan‘s Partnering Business has grown by an average rate of more than 9% per year and, with several newly signed development and supply agreements, it is well positioned for further growth. His deep understanding of the end-markets and his application expertise will help the company to further benefit from major growth drivers and expand Tecan‘s position as a complete solution provider in select applications,” commented Dr. Martyr.

Dr. Martyr leaves the position after six-and-a-half years (see IBO 2/15/12). Dr. von Leoprechting joined Tecan in 2013 as head of the Partnering Business (see IBO 9/15/13). His has experience with both the life science research and IVD end-markets.